Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for Mansonella Perstans Infection
NCT00340691Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2004
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in Mansonella perstans infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2004; status: completed.
02
Drugs
doxycycline
03
Conditions
Mansonella perstans infection
Beyond the preview
Go deeper on NCT00340691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00340691.